NDC 52244-429

Robaxin

Methocarbamol

Robaxin is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Endo Pharmaceuticals, Inc.. The primary component is Methocarbamol.

Product ID52244-429_e4bc191a-b475-4212-bc1d-f085ecc76572
NDC52244-429
Product TypeHuman Prescription Drug
Proprietary NameRobaxin
Generic NameMethocarbamol
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2012-05-15
Marketing CategoryNDA / NDA
Application NumberNDA011011
Labeler NameEndo Pharmaceuticals, Inc.
Substance NameMETHOCARBAMOL
Active Ingredient Strength500 mg/1
Pharm ClassesCentrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 52244-429-10

100 TABLET, FILM COATED in 1 BOTTLE (52244-429-10)
Marketing Start Date2012-05-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 52244-429-10 [52244042910]

Robaxin TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA011011
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-05-15
Marketing End Date2019-02-28

Drug Details

Active Ingredients

IngredientStrength
METHOCARBAMOL500 mg/1

OpenFDA Data

SPL SET ID:0db1e8dd-b4fa-491b-a529-0fb939710759
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 207016
  • 197943
  • 197944
  • 1010654
    • UPC Code
  • 0352244429100
  • 0352244449108

    • Pharmacological Class

    • Centrally-mediated Muscle Relaxation [PE]
    • Muscle Relaxant [EPC]

    NDC Crossover Matching brand name "Robaxin" or generic name "Methocarbamol"

    NDCBrand NameGeneric Name
    0641-6103ROBAXINmethocarbamol
    0641-6217ROBAXINmethocarbamol
    52244-429RobaxinRobaxin
    52244-449RobaxinRobaxin
    61919-354ROBAXINROBAXIN
    80425-0021RobaxinRobaxin
    80425-0020RobaxinRobaxin
    0143-1290MethocarbamolMethocarbamol
    0143-1292MethocarbamolMethocarbamol
    0179-0092MethocarbamolMethocarbamol
    0276-0510MethocarbamolMethocarbamol
    0404-9909MethocarbamolMethocarbamol
    0440-1740Methocarbamolmethocarbamol
    0517-1825Methocarbamolmethocarbamol
    0603-4485Methocarbamolmethocarbamol
    0603-4486Methocarbamolmethocarbamol
    0615-7572Methocarbamolmethocarbamol
    0615-7573Methocarbamolmethocarbamol
    0615-8435METHOCARBAMOLMETHOCARBAMOL
    0615-8436METHOCARBAMOLMETHOCARBAMOL
    0904-7057MethocarbamolMethocarbamol
    0904-7058MethocarbamolMethocarbamol
    10135-664MethocarbamolMethocarbamol
    10135-665MethocarbamolMethocarbamol
    10544-259MethocarbamolMethocarbamol
    10544-464MethocarbamolMethocarbamol
    10544-622MethocarbamolMethocarbamol
    10544-773MethocarbamolMethocarbamol
    10544-956Methocarbamolmethocarbamol
    17511-505METHOCARBAMOLMETHOCARBAMOL
    17511-506METHOCARBAMOLMETHOCARBAMOL
    21695-078MethocarbamolMethocarbamol
    21695-079MethocarbamolMethocarbamol
    10135-722Methocarbamol Tablets, USP, 500 mgMethocarbamol
    10135-723Methocarbamol Tablets, USP, 750 mgMethocarbamol

    Trademark Results [Robaxin]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ROBAXIN
    ROBAXIN
    72024798 0651130 Live/Registered
    A.H. ROBINS COMPANY, INC.
    1957-02-20
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.